Discovery of the Phosphonate Flavophos Produced by Burkholderia

This study identifies and characterizes flavophos, a novel phosphonate antibiotic produced by *Burkholderia* that inhibits lumazine synthase, through the heterologous expression of its biosynthetic gene cluster and the structural elucidation of a divergent DUF849 enzyme involved in its synthesis.

The Gist

The Big Picture: Finding a New "Chemical Weapon" in the Microbial World

Imagine the bacterial world as a massive, bustling city. In this city, different neighborhoods (species of bacteria) have secret recipes for making special tools. Some of these tools are antibiotics (weapons to kill neighbors), and some are herbicides (tools to clear weeds).

Scientists have been looking for a specific type of tool called a phosphonate. Think of a phosphonate as a "molecular spy." It looks so much like a key that bacteria use to open their doors (metabolic enzymes) that it gets stuck in the lock, jamming the machinery and stopping the bacteria from working.

In this study, a team of researchers went on a digital treasure hunt through the genetic blueprints (genomes) of a bacterium called Burkholderia. They were looking for a specific set of instructions (a gene cluster) that builds these phosphonate spies.

The Discovery: "Flavophos"

They found a hidden recipe in Burkholderia that they hadn't seen before. They named the resulting chemical Flavophos.

To prove it worked, they took the recipe out of the Burkholderia and gave it to a harmless lab bacterium, E. coli (like giving a human a recipe for a cake and asking a hamster to bake it). The hamster (E. coli) successfully baked the cake (Flavophos), and when they tested it, it successfully stopped other bacteria from growing.

The Mystery of the "Wrong" Tool

The recipe for Flavophos included a specific machine called BsfD. In the bacterial world, this machine usually belongs to a family known as "Beta-Keto Acid Cleavage Enzymes" (BKACEs).

The Analogy: Imagine a standard BKACE machine is a wood chopper. Its job is to take a long log (a molecule) and chop it into two specific pieces: a small block and a long plank. Scientists expected BsfD to work exactly like this wood chopper.

However, when they watched BsfD in action, it didn't chop the log. Instead, it acted like a molecular sculptor. It took the raw materials and rearranged them into a completely different shape: 2,4-dioxopentylphosphonic acid (the chemical name for Flavophos).

The scientists were shocked. They used high-tech X-ray cameras (crystallography) to look at the machine up close. They found that BsfD had a tiny, unique "twist" in its design (a specific amino acid change) that forced it to work differently than its cousins. It was like finding a wood chopper that had been secretly modified to carve intricate statues instead of splitting firewood.

The Target: Jamming the "Flavin Factory"

So, what does Flavophos actually do to kill bacteria?

Every living thing needs a special vitamin called Riboflavin (Vitamin B2) to survive. Bacteria make this vitamin in a factory called the Lumazine Synthase (LS) assembly line.

• The Lock: The factory needs a specific raw material (a molecule called DHBP) to build the vitamin.
• The Spy: Flavophos looks exactly like that raw material.
• The Trap: When Flavophos sneaks into the factory, it jams the assembly line. The factory thinks it's making the vitamin, but it's actually building a useless, broken product. The factory shuts down, the bacteria runs out of energy, and it dies.

The "Self-Defense" Mechanism

Here is the clever part: The bacteria that make Flavophos don't kill themselves. Why? Because their recipe book (the gene cluster) includes a shield.

This shield is a duplicate copy of the factory machine (Lumazine Synthase) that is slightly different. It's like the bacteria built a "bouncer" that recognizes the fake key (Flavophos) and throws it out before it can jam the real factory.

The researchers tested this by giving the "bouncer" gene to other bacteria. Suddenly, those bacteria became immune to Flavophos! They could handle the chemical weapon without dying.

Why This Matters

1. New Antibiotics: We are in an arms race with superbugs. Finding new chemical weapons like Flavophos gives us new ways to fight infections.
2. New Science: This study showed that nature is full of surprises. A machine we thought was a "wood chopper" turned out to be a "sculptor." This helps scientists understand how evolution tweaks tools to create new functions.
3. New Targets: Since Flavophos targets the Vitamin B2 factory, and that factory is essential for almost all life, it opens up a new avenue for designing drugs that can stop bacteria (and potentially weeds) by cutting off their vitamin supply.

In short: Scientists found a new bacterial weapon, figured out how it's built by a unique machine, discovered it kills by jamming the vitamin factory, and found the secret shield the bacteria use to protect themselves.

Technical Summary

1. Problem Statement

Phosphonate natural products are valuable antibiotics and herbicides that function by mimicking phosphate esters or tetrahedral intermediates to inhibit enzymes. While the biosynthesis of many phosphonates is well-characterized (often deriving from phosphoenolpyruvate via phosphoenolpyruvate phosphomutase, PepM), the diversity of these pathways remains underexplored. Specifically, the fate of the intermediate 2-phosphonomethylmalate (2-Pmm) in certain biosynthetic clusters was unclear. Furthermore, the Burkholderia genus contains numerous phosphonate biosynthetic gene clusters (BGCs) with unknown products and enzymatic mechanisms. The study aimed to identify new phosphonate natural products from Burkholderia, elucidate their biosynthetic pathways, characterize novel enzymatic activities, and determine their biological targets.

2. Methodology

The researchers employed a multi-disciplinary approach combining bioinformatics, heterologous expression, structural biology, chemical synthesis, and biochemical assays:

• Bioinformatics & Genome Mining:
  • Used the Enzyme Function Initiative Enzyme Similarity Tools (EFI-EST) to generate Sequence Similarity Networks (SSN) and Genomic Neighborhood Networks (GNN) based on the 2-Pmm synthase (PsfB) protein.
  • Filtered clusters for the presence of pepM genes and absence of decarboxylases to identify novel BGC families.
  • Identified a specific cluster family (GCF 3) restricted to Burkholderia species.
• Heterologous Expression:
  • Cloned the Burkholderia BGC (bsf) and related genes (psfABC from Pseudomonas) into Escherichia coli.
  • Co-expressed the Burkholderia enzyme BsfD with the Pseudomonas pathway enzymes to generate the substrate 3-oxo-4-phosphonobutanoate (3-OBPn) and observe downstream products.
  • Screened cell lysates for antimicrobial activity against an engineered E. coli strain (WM6242 λ(DE3)) with an inducible phosphonate transporter (phn operon).
• Structural Biology:
  • Purified the enzyme BsBsfD (an ortholog from B. stagnalis) and determined its crystal structures in four states: apo, CoA-bound, substrate-bound (short soak), and product-bound (long soak).
  • Used X-ray crystallography (synchrotron data) to resolve structures at resolutions ranging from 1.5 Å to 1.81 Å.
• Chemical Synthesis & NMR:
  • Synthesized the predicted product, 2,4-dioxopentylphosphonic acid, to confirm the structure of the natural product via spiking experiments in NMR.
  • Utilized $^{31}$P, $^{1}$H, $^{13}$C NMR, and LC-MS to characterize reaction intermediates and products.
• Target Identification:
  • Tested resistance conferred by overexpressing Lumazine Synthase (LS) genes (both from the BGC and various other organisms) in E. coli.
  • Performed in vitro inhibition assays of LS using purified enzymes and flavophos.
  • Generated spontaneous resistance mutants in E. coli and sequenced their genomes to identify resistance mechanisms.

3. Key Contributions

• Discovery of Flavophos: Identification and structural assignment of a new phosphonate natural product named flavophos (2,4-dioxopentylphosphonic acid).
• Novel Enzymatic Mechanism: Characterization of BsfD, a member of the DUF849 family (homologous to $\beta$-keto acid cleavage enzymes, BKACEs), which catalyzes a divergent reaction compared to canonical BKACEs.
• Structural Insight: Determination of crystal structures revealing a unique mechanism where the CoA 3'-phosphoadenosine moiety flips to occlude the active site, facilitating a specific rearrangement rather than the standard retro-Claisen cleavage.
• Target Validation: Demonstration that flavophos targets Lumazine Synthase (LS), an essential enzyme in riboflavin (vitamin B2) biosynthesis, acting as a substrate mimic.

4. Key Results

• Biosynthetic Pathway:
  • The bsf BGC encodes PepM (BsfA), 2-Pmm synthase (BsfF), a 2-Pmm to 3-OBPn converter (BsfC), and the novel enzyme BsfD.
  • Unlike the fosfomycin pathway where 3-OBPn is decarboxylated to 2-oxopropylphosphonate, BsfD converts 3-OBPn into flavophos (2,4-dioxopentylphosphonic acid).
  • BsfD Activity: While canonical BKACEs cleave $\beta$-keto acids to form acetoacetate and a CoA-thioester, BsfD catalyzes a reaction that retains the carbon skeleton to form a 5-carbon phosphonate.
• Structural Mechanism of BsfD:
  • BsBsfD adopts a TIM-barrel fold with a catalytic Zn$^{2+}$ ion coordinated by His48, His50, and Glu247.
  • Unique Conformational Change: In the presence of substrates, the CoA 3'-phosphoadenosine flips toward the active site, creating a closed cavity. This movement displaces the CoA pantetheine arm, preventing the standard retro-Claisen cleavage seen in other BKACEs.
  • Substrate Specificity: An insertion loop containing Arg91 stabilizes the phosphonate group, explaining the enzyme's preference for phosphonate substrates over standard $\beta$-keto acids.
  • Mutagenesis: Replacing the unique Phe166 with Tyr (to mimic canonical BKACEs) rendered the protein insoluble, suggesting this residue is critical for the enzyme's unique folding or function.
• Biological Activity & Target:
  • Flavophos exhibits antimicrobial activity against E. coli.
  • Resistance Mechanism: Overexpression of Lumazine Synthase (LS) from Burkholderia, E. coli, B. subtilis, Aquifex aeolicus, and Mycobacterium tuberculosis confers resistance to flavophos.
  • Inhibition: In vitro assays show flavophos inhibits LS activity. Mass spectrometry suggests flavophos reacts with the LS substrate (5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione) to form stable adducts (mimicking the transition state or intermediate), effectively poisoning the enzyme.
  • Resistance Mutants: Spontaneous resistance mutants in E. coli were found to have mutations in the phn transporter operon, preventing uptake, rather than mutations in the LS gene itself. This confirms LS is the target but uptake is required for toxicity.

5. Significance

• New Chemical Space: The discovery of flavophos expands the known structural diversity of phosphonate natural products, specifically those derived from the 2-Pmm intermediate.
• Enzymatic Diversity: The study redefines the functional scope of the DUF849/BKACE family, showing that these enzymes can catalyze reactions distinct from the canonical retro-Claisen cleavage, driven by specific structural rearrangements (CoA flipping).
• Antibiotic Target: It identifies Lumazine Synthase as a viable target for phosphonate-based antibiotics. Since riboflavin biosynthesis is essential in bacteria but absent in humans (who acquire it from diet), this pathway is an attractive target for new antimicrobial development.
• Self-Immunity Strategy: The presence of an LS homolog (bsfB) within the BGC provides a natural mechanism for the producing organism to resist its own toxin, a common but mechanistically diverse strategy in natural product biosynthesis.

In conclusion, this work successfully links a genomic prediction to a novel chemical structure, elucidates a unique enzymatic mechanism via structural biology, and validates a specific biological target, offering a blueprint for future discovery of phosphonate antibiotics.